Avecho Biotechnology. has filed a patent for an oral cannabinoid formulation containing a cannabinoid, long chain triglyceride or long chain fatty acid carrier, and tocopheryl phosphate components. The mass ratio of cannabinoid to tocopheryl phosphate is between 10:1 to 1:10. GlobalData’s report on Avecho Biotechnology gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Avecho Biotechnology Ltd - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Avecho Biotechnology, Nanoparticle drug conjugates was a key innovation area identified from patents. Avecho Biotechnology's grant share as of January 2024 was 28%. Grant share is based on the ratio of number of grants to total number of patents.

Oral cannabinoid formulation with specific components and ratios